As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Cell-free DNA analysis in colorectal cancer patients
Editorial board member Michael Speicher and colleagues use cell-free DNA analyses to track evolving tumor genomes.
Pan-cancer landscape of prognostic germline variants
Anindya Dutta and colleagues identify germline variants predictive of outcome in cancer patients.
Clinical interpretation of genome variation
Read our latest special issue, guest edited by Heidi Rehm and Douglas Fowler.
European health research and innovation cloud
Editorial board member Charles Auffray and colleagues describe their vision and benefits of digital data sharing.
Reviews, Research Highlights and Commentaries
Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Articles
-
-
Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
-
Tracking cancer progression: from circulating tumor cells to metastasis
-
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma
-
Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
-
The virome: a missing component of biological interaction networks in health and disease
-
Impact of the gut microbiota on inflammation, obesity, and metabolic disease
Focus: Pathogens
Read the latest papers on pathogenic organisms and disease across BMC flagship journals.
Population-level mathematical modeling of antimicrobial resistance: a systematic review
Anna Maria Niewiadomska et al.
Published in BMC Medicine 24 April 2019
A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk
Elvire Berthenet et al.
Published in BMC Biology 02 August 2018
INSaFLU: an automated open web-based bioinformatics suite “from-reads” for influenza whole-genome-sequencing-based surveillance
Vítor Borges et al.
Published in Genome Medicine 29 June 2018
HOPS: automated detection and authentication of pathogen DNA in archaeological remains
Ron Hübler et al.
Published in Genome Biology 16 December 2019
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Collection
A decade of Genome Medicine
Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
Special issue
Genomics of infection and immunity
Guest editors: Bali Pulendran and Mark Davis
From the blog
-
-
A Map for Drug Discovery
28 February 2020
-
Rare Disease Day Quiz 2020
28 February 2020
Advertisement
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
-
Announcements
In response to the current outbreak of Coronavirus, responsible for COVID-19, Genome Medicine editors will treat relevant submissions with high priority.
Follow
2018 Journal Metrics
-
Citation Impact
10.886 - 2-year Impact Factor
9.368 - 5-year Impact Factor
1.833 - Source Normalized Impact per Paper (SNIP)
5.084 - SCImago Journal Rank (SJR)
Advertisement
